- Home
- USNA vs ABUS Comparison
USNA vs ABUS Comparison
Compare USNA & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- ABUS
- Stock Information
- Founded
- USNA 1992
- ABUS N/A
- Country
- USNA United States
- ABUS United States
- Employees
- USNA N/A
- ABUS N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- ABUS Health Care
- Exchange
- USNA Nasdaq
- ABUS Nasdaq
- Market Cap
- USNA 636.2M
- ABUS 629.1M
- IPO Year
- USNA 1996
- ABUS N/A
- Fundamental
- Price
- USNA $34.48
- ABUS $3.21
- Analyst Decision
- USNA Hold
- ABUS Strong Buy
- Analyst Count
- USNA 1
- ABUS 4
- Target Price
- USNA $38.00
- ABUS $5.50
- AVG Volume (30 Days)
- USNA 127.7K
- ABUS 876.5K
- Earning Date
- USNA 02-04-2025
- ABUS 02-27-2025
- Dividend Yield
- USNA N/A
- ABUS N/A
- EPS Growth
- USNA N/A
- ABUS N/A
- EPS
- USNA 2.83
- ABUS N/A
- Revenue
- USNA $861,973,000.00
- ABUS $6,742,000.00
- Revenue This Year
- USNA N/A
- ABUS N/A
- Revenue Next Year
- USNA $11.73
- ABUS N/A
- P/E Ratio
- USNA $12.07
- ABUS N/A
- Revenue Growth
- USNA N/A
- ABUS N/A
- 52 Week Low
- USNA $31.44
- ABUS $2.27
- 52 Week High
- USNA $52.75
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- USNA 43.80
- ABUS 43.07
- Support Level
- USNA $33.34
- ABUS $3.16
- Resistance Level
- USNA $36.99
- ABUS $3.38
- Average True Range (ATR)
- USNA 0.94
- ABUS 0.14
- MACD
- USNA 0.01
- ABUS 0.00
- Stochastic Oscillator
- USNA 35.31
- ABUS 19.51
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.